PMV Pharmaceuticals to Participate at Upcoming Investor Conferences

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President and Chief Executive Officer and Deepika Jalota, Pharm. D., Chief Development Officer, will participate at the following investor conferences. Management will also participate in one-on-one investor meetings.

Oppenheimer 35th Annual Healthcare Life Sciences Conference
Date: Wednesday, February 12, 2025
Time: 12:40 PM EST

TD Cowen 45th Annual Health Care Conference
Date: Tuesday, March 4, 2025
Time: 3:10 PM EST

A live audio webcast of the events will be available online at Events & Presentations. An archived replay of the events will be available for 90 days following the webcast at Events & Presentations.

About PMV Pharma

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53. TP53 mutations are found in approximately half of all cancers. Our co-founder, Dr. Arnold Levine, established the field of p53 biology when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize more than four decades of p53 biology, PMV Pharma combines unique biological understanding with a pharmaceutical development focus. PMV Pharma is headquartered in Princeton, New Jersey. For more information, please visit www.pmvpharma.com.

Investors Contact:
Tim Smith
Senior Vice President, Head of Corporate Development and Investor Relations
investors@pmvpharma.com

Media Contact:
Kathy Vincent
Greig Communications
kathy@greigcommunications.com

Staff

Recent Posts

Launched at Breakthrough 2025, ArisGlobal announces LifeSphere Unify, NavaX Insights, and Advanced Compliance Docs

ZURICH, March 19, 2025 /PRNewswire/ -- ArisGlobal, a leading life sciences technology company and creator…

2 hours ago

Institute for Supply Management® Expands to End-to-End Supply Chain

ISM® updates its mission and offerings to serve practitioners across the global supply chain TEMPE, Ariz.,…

8 hours ago

HealthTree Foundation Launches Leif, the HealthTree AI Assistant

New AI-Powered Support Assistant Helps Blood Cancer Patients Find Answers and Resources Faster SALT LAKE…

8 hours ago

Subtle Medical Advances GenAI Innovation in Radiology with NVIDIA

Leveraging NVIDIA's Latest GPU Architecture to Accelerate Innovations in Ultra-Low-Dose Imaging and Enhanced Lesion Visualization…

14 hours ago

Moon Surgical to Accelerate AI Capabilities in Maestro System with NVIDIA Isaac for Healthcare

PARIS and SAN FRANCISCO, March 18, 2025 /PRNewswire/ -- Moon Surgical, a French-American pioneer in surgical…

14 hours ago